A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.
About This Bill
Committee
Latest Action · February 11, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.